NAC459.2923. Specific licenses: Manufacture or initial transfer of calibration or reference sources.  


Latest version.
  • An application for a specific license to manufacture or initially transfer calibration or reference sources which contain americium-241 or radium-226 for distribution to a person who holds a general license issued pursuant to NAC 459.224 will be approved:

         1. If the applicant satisfies the general requirements of NAC 459.238;

         2. If the applicant submits sufficient information regarding each type of calibration or reference source relating to the evaluation of the potential radiation exposure, including, without limitation:

         (a) The chemical and physical form of the source and maximum quantity of americium-241 or radium-226 in the source;

         (b) The details of construction and design of the source;

         (c) The details of the method of incorporation and binding of the americium-241 or radium-226 in the source;

         (d) The procedure for and results of a prototype testing of a source designed to contain more than 0.005 microcurie (185 becquerels) of americium-241 or radium-226 in order to demonstrate that the americium-241 or radium-226 contained in each source will not be released or removed from the source under normal conditions of use;

         (e) The details of quality control procedures which will be followed in the manufacture of the source;

         (f) A description of the labeling to be affixed to the source or the storage container for the source; and

         (g) Any additional information, including experimental studies and tests, required by the Division to facilitate a determination of the safety of the source;

         3. If each source contains not more than 5 microcuries (185 kilobecquerels) of americium-241 or radium-226; and

         4. If the Division determines, for any source which contains more than 0.005 microcurie (185 becquerels) of americium-241 or radium-226 that:

         (a) The method of incorporation and binding of the americium-241 or radium-226 in the source is such that the americium-241 or radium-226 will not be released or removed from the source under normal conditions of use and handling of the source; and

         (b) The source has been subjected to, and has passed in a satisfactory manner, the prototype tests prescribed by 10 C.F.R. § 32.102, Schedule C, as it existed on November 30, 2007, or an equivalent regulation of an agreement state.

     (Added to NAC by Bd. of Health by R185-08, eff. 5-7-2010)